| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 16 | -454K | 100% | $141.82 | -$64.3M |
| Net | -16 | -454K | -100% | -$64.3M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Kevin Charles Gorman | Director | $66.1M | -$23.2M | -26% | Feb 13, 2025 |
| Kyle Gano | Chief Executive Officer, Director | $18.3M | -$9.85M | -35% | Feb 12, 2025 |
| Gary A. Lyons | Director | $18.1M | -$3.58M | -16.5% | Aug 13, 2024 |
| Dimitri E. Grigoriadis | Chief Research Officer | $15.6M | Jan 31, 2022 | ||
| Darin Lippoldt | Chief Legal Officer | $10M | -$2.07M | -17.1% | Feb 12, 2025 |
| Eric Benevich | Chief Commercial Officer | $6.95M | -$552K | -7.36% | Feb 12, 2025 |
| Malcolm Lloyd-Smith | Chief Integration Officer | $5.92M | Feb 6, 2023 | ||
| William H. Rastetter | Director | $5.91M | -$2.09M | -26.1% | Aug 15, 2024 |
| Matt Abernethy | Chief Financial Officer | $5.37M | -$7M | -56.6% | Feb 12, 2025 |
| Eiry Roberts | Chief Medical Officer | $5.23M | -$597K | -10.2% | Feb 12, 2025 |
| Richard F. Pops | Director | $4.89M | -$298K | -5.74% | May 22, 2024 |
| Jude Onyia | Chief Scientific Officer | $4.49M | -$650K | -12.7% | Feb 12, 2025 |
| Julie Cooke | Chief Human Resources Officer | $3.59M | -$4M | -52.7% | Feb 12, 2025 |
| Ingrid Delaet | Chief Regulatory Officer | $2.11M | -$2.17M | -50.7% | Feb 12, 2025 |
| David W. Boyer | Chief Corp. Affairs Officer | $2.1M | -$1.03M | -32.9% | Feb 12, 2025 |
| Stephen Sherwin | Director | $1.65M | -$6.95M | -80.8% | Feb 13, 2025 |
| Morrow George J | Director | $1M | May 22, 2024 | ||
| Johanna Mercier | Director | $718K | May 22, 2024 | ||
| Shalini Sharp | Director | $564K | -$157K | -21.8% | May 22, 2024 |
| Leslie V. Norwalk | Director | $564K | -$157K | -21.8% | May 22, 2024 |
| Christine A. Poon | Director | $423K | May 22, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|